Denali Therapeutics
DNLI
DNLI
221 hedge funds and large institutions have $1.81B invested in Denali Therapeutics in 2025 Q1 according to their latest regulatory filings, with 36 funds opening new positions, 73 increasing their positions, 80 reducing their positions, and 35 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
221
Holders Change
-2
Holders Change %
-0.9%
% of All Funds
3%
Holding in Top 10
1
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-50%
% of All Funds
0.01%
New
36
Increased
73
Reduced
80
Closed
35
Calls
$848K
Puts
$515K
Net Calls
+$333K
Net Calls Change
-$267K
Top Buyers
| 1 |
UBS AM
Chicago,
Illinois
|
+$43.3M |
| 2 |
Wellington Management Group
Boston,
Massachusetts
|
+$21.2M |
| 3 |
T. Rowe Price Associates
Baltimore,
Maryland
|
+$17.8M |
| 4 |
Millennium Management
New York
|
+$14.8M |
| 5 |
Squarepoint
New York
|
+$8.68M |
